In particular, adherence to the program revealed a double positive effect: on the one hand, it improved insulin resistance conditions and, on the other, could prevent possible deterioration, as was suggested by the control arm trend, particularly for glycaemia, and HOMA-IR index changes, and the reduction in the IGF-binding protein 3 in these unsupervised patients. This evidence concerns the gene IGFBP3 and Insulin resistance.